Human herpesvirus 3
Human herpesvirus 3
规格:
货期:
编号:TS213713
品牌:Testobio
| 产品名称： | Human herpesvirus 3 |
|---|---|
| 商品货号： | TS213713 |
| Classification： | Herpesviridae, Varicellovirus |
| Deposited As： | Varicella-Zoster |
| Agent： | Human herpesvirus 3 |
| Strain： | AV92-3:L (low passage) |
| Common Name： | Varicella zoster virus |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Vapor phase of liquid nitrogen |
| Comments： | Frozen infected cells and supernate |
| Effect on Host： | CPE (slowly developing focal rounding and sloughing) |
| Recommended Host： | BS-C-1 cells (ATCC® CCL-26™) |
| Growth Conditions： | Incubation: 5-7 days at 37°C |
| Name of Depositor： | A Vafai |
| Special Collection： | NCRR Contract |
| Source： | Patient with zoster |
| References： | Vafai A. Antibody-binding sites on truncated forms of varicella-zoster virus gpI(gE) glycoprotein. Vaccine 12: 1265-1269, 1994. PubMed: 7531921 |
首页 >
产品中心
>
微生物培养
>
菌株
>
null
>
Human herpesvirus 3
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Human herpesvirus 3 |
|---|---|
| 商品货号： | TS213713 |
| Classification： | Herpesviridae, Varicellovirus |
| Deposited As： | Varicella-Zoster |
| Agent： | Human herpesvirus 3 |
| Strain： | AV92-3:L (low passage) |
| Common Name： | Varicella zoster virus |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Storage Conditions： | Vapor phase of liquid nitrogen |
| Comments： | Frozen infected cells and supernate |
| Effect on Host： | CPE (slowly developing focal rounding and sloughing) |
| Recommended Host： | BS-C-1 cells (ATCC® CCL-26™) |
| Growth Conditions： | Incubation: 5-7 days at 37°C |
| Name of Depositor： | A Vafai |
| Special Collection： | NCRR Contract |
| Source： | Patient with zoster |
| References： | Vafai A. Antibody-binding sites on truncated forms of varicella-zoster virus gpI(gE) glycoprotein. Vaccine 12: 1265-1269, 1994. PubMed: 7531921 |
